Perindopril inhibits aldosterone biosynthesis and CYP11B2 mRNA expression in heart of rats with congestive heart failure

修建成,吴平生,徐静萍,郭志刚,张远慧,刘伊丽
DOI: https://doi.org/10.3969/j.issn.1009-0126.2002.03.013
2002-01-01
Abstract:Objective To evaluate the potential action of perindopril,an angiotensin converting enzyme inhibitor, on congestive heart failure rats after myocardial infarction. Methods Male Wistar rats with infarction induced congestive heart failure were treated with perindopril (3 mg/kg per day).Rats with untreated chronic heart failure and sham operated rats were used as positive and normal controls. By means of ex vivo heart perfusion, HPLC, radioimmunoassay and RT PCR,the levels of angiotensin Ⅱ, aldosterone and CYP11B2 gene expression in hearts of the rats were measured.Results Aldosterone production was increased in the heart perfusates of the rats with infarction induced chronic heart failure rats (1?077.7±39.9 mg/h) as compared with that of the sham operated rats(500.3±20.6 mg/h), and CYP11B2 gene expression was enhanced in the noninfarction myocardium. Although perindopril could not inhibit the increases in Ang Ⅱ and aldosterone in plasma,it decreased the levels of Ang Ⅱ and aldosterone in the heart perfusates and inhibited the CYP11B2 gene expression in the noninfarction myocardium. Conclusions Production of aldosterone was increased in the hearts of congestive heart failure rats. Long term perindopril treatment did inhibit aldosterone production in the heart of chronic heart failure rats.
What problem does this paper attempt to address?